Barclays »

Harvard Bioscience shares owned by Barclays

Quarter-by-quarter ownership of Harvard Bioscience (HBIO) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Harvard Bioscience

Tip: Access up to 7 years of quarterly data

All positions including Harvard Bioscience held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Harvard Bioscience by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $159 26 6.15

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Harvard Bioscience

Weber Capital Management
Acadian Asset Management
Vanguard Capital Management
Corsair Capital Management
Two Sigma Investments
Renaissance Technologies
BlackRock
Geode Capital Management
Mink Brook Asset Management
Millennium Management
Vanguard Fiduciary Trust
Essex Investment Management
Williams & Novak
UBS Group
Rbf Capital

View all funds holding Harvard Bioscience